首页> 外文期刊>Canadian Urological Association Journal >Northeastern Section of the American Urological Association 64th Annual Meeting, Niagara Falls, Ontario Scientific Program
【24h】

Northeastern Section of the American Urological Association 64th Annual Meeting, Niagara Falls, Ontario Scientific Program

机译:美国泌尿科协会第64届年会东北部,安大略省科学计划,尼亚加拉瀑布

获取原文
           

摘要

Background: Infections following prostate biopsy can be associated with significant morbidity and occasional mortality. Studies have suggested an increased incidence in post-biopsy sepsis. The purpose of this study was to determine the effect of a bacteria sensitivity adapted antimicrobial prophylactic strategy on the incidence of sepsis post prostate biopsy. Methods: In October 2008, based on the prevalence of ciprofloxacin-resistant E.coli in the region, our institution modified the prophylactic regimen for prostate biopsy from oral ciprofloxacin alone to a combination of single-dose ciprofloxacin and trimethoprim/sulfamethoxazole. If patients had a history of urosepsis, bacterial prostatitis, organ transplant, or fluoroquinolone use in the preceding 12 months, intramuscular ceftriaxone was administered for prophylaxis. Patients with penicillin allergy received gentamicin. We determined the incidence of ciprofloxacin-resistant bacteremia 16 months before and 16 months after the change in antibiotic protocol. Results: Between June 2007 and September 2008, 9 of 847 (1.06%) patients were admitted with prostate biopsy induced bacteremia secondary to ciprofloxacin-resistant E. coli. In the 16 months following introduction of the described prophylactic regimen, 1 of 989 (0.10%) patients suffered ciprofloxacin-resistant sepsis. The absolute reduction in E. coli sepsis was 0.96% (95%CI 0.2% to 1.7%; p =0.007). The number needed to treat is 104. Conclusions: Bacterial susceptibility to antimicrobial agents is in evolution. Using a regional bacteria sensitivity based approach to biopsy prophylaxis, we have significantly decreased ciprofloxacin-resistant E. coli sepsis in our patients. Regional bacteria sensitivity based protocols may decrease the incidence at other centers and warrants further study. Can Urol Assoc J. 2012 Aug; 6(4): 275–325. ? P2: The Impact of Concomitant Carcinoma In Situ on Upstaging Following Radical Cystectomy for Bladder Cancer Can Urol Assoc J. 2012 Aug; 6 (4) : 284. P2: The Impact of Concomitant Carcinoma In Situ on Upstaging Following Radical Cystectomy for Bladder Cancer Faysal A. Yafi ,1 Armen G. Aprikian ,1 Joseph L. Chin ,2 Yves Fradet ,3 Jonathan Izawa ,2 Eric Estey ,4 Adrian Fairey ,4 Ricardo Rendon ,5 Ilias Cagiannos ,6 Louis Lacombe ,3 Jean-Baptiste Lattouf ,7 David Bell ,5 Darrel Drachenberg ,8 and Wassim Kassouf 1 1McGill University, Montreal, QC, Canada 2University of Western Ontario, London, ON, Canada 3Laval University, Quebec, QC, Canada 4University of Alberta, Edmonton, AB, Canada 5Dalhousie University, Halifax, NS, Canada 6University of Ottawa, Ottawa, ON, Canada 7University of Montreal, Montreal, QC, Canada 8University of Manitoba, Winnipeg, MB, Canada Author information ? Copyright and License information ? Copyright : ? 2012 Canadian Urological Association or its licensors
机译:背景:前列腺活检后的感染可能与明显的发病率和偶发的死亡率有关。研究表明活检后败血症的发生率增加。这项研究的目的是确定适应细菌敏感性的抗菌预防策略对前列腺活检后败血症发生率的影响。方法:2008年10月,根据该地区对环丙沙星耐药的大肠杆菌的流行情况,我们将前列腺穿刺活检的预防方案从口服环丙沙星改为单剂量环丙沙星和甲氧苄氨嘧啶/磺胺甲基异恶唑的组合。如果患者在之前的12个月中有尿毒症,细菌性前列腺炎,器官移植或使用氟喹诺酮的病史,则应进行肌肉内头孢曲松钠的预防。对青霉素过敏的患者接受庆大霉素治疗。我们确定了抗生素方案变更前16个月和变更后16个月耐环丙沙星菌血症的发生率。结果:在2007年6月至2008年9月之间,有847例患者中有9例(1.06%)接受了前列腺穿刺术诱导的继发于环丙沙星耐药的大肠杆菌的菌血症。在引入所述预防性方案后的16个月中,989名患者中有1名(0.10%)患有环丙沙星耐药的脓毒症。大肠杆菌败血症的绝对减少为0.96%(95%CI为0.2%至1.7%; p = 0.007)。需要治疗的数量为104。结论:细菌对抗菌剂的敏感性正在发展。使用基于区域细菌敏感性的方法进行活检预防,我们显着降低了患者的环丙沙星耐药性大肠杆菌败血症。基于区域细菌敏感性的方案可能会降低其他中心的发病率,值得进一步研究。 Can Urol Assoc J.2012年8月; 6(4):275–325。 ? P2:膀胱癌根治性膀胱切除术同时发生的原位癌对分期升级的影响Can Urol Assoc J. 2012年8月; 6(4):284. P2:膀胱癌根治性膀胱切除术后伴随癌原位分期对Faysal A. Yafi, 1 Armen G. Aprikian, 1 约瑟夫·钦(Joseph L. Chin), 2 伊夫·弗雷德(Yves Fradet), 3 乔纳森·伊泽瓦(Jonathan Izawa), 2 埃里克·埃斯蒂(Eric Estey), 4 阿德里安·费尔雷(Adrian Fairey),< sup> 4 里卡多·伦登(Ricardo Rendon), 5 伊利亚斯·卡吉诺诺斯(Ilias Cagiannos), 6 路易斯·拉科姆(Louis Lacombe), 3 尚·巴蒂斯特·拉托夫(Jean-Baptiste Lattouf), 7 < / sup> David Bell, 5 Darrel Drachenberg, 8 和Wassim Kassouf 1 1 麦吉尔大学,蒙特利尔,质量控制,加拿大 2 加拿大安大略省伦敦市的西安大略大学 3 加拿大魁北克省魁北克的拉瓦尔大学 4 艾伯塔大学,埃德蒙顿, AB,加拿大 5 达尔豪斯大学,哈利法克斯,NS,加拿大 6 渥太华大学,渥太华,安大略省,加拿大 7 蒙特利尔大学,蒙特利尔, QC,加拿大 8 曼尼托巴大学,温尼伯,MB,加拿大作者信息?版权和许可信息?版权: 2012年加拿大泌尿科协会或其许可人

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号